Home

The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.

About


The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.

IDCRC Active & Completed Studies
IDCRC Logo

Contributing to Advance COVID-19 Therapeutics

IDCRC-VTEU sites supported ACTT 1-4 studies

Results
COVID-19 Vaccine Appears Well-Tolerated and Effective in Developing Antibodies in Small Study of Older Adults

COVID-19 Prevention Network

The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.

More about the CoVPN
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies

IDCRC Sites Across the Nation


IDCRC Leadership Group

Emory University School of Medicine

University of Maryland Baltimore

Baylor College of Medicine

Cincinnati Children’s Hospital Medical Center

FHI 360

Fred Hutch

University of Alabama School of Medicine

Johns Hopkins School of Medicine

Vanderbilt University Medical Center

University of Washington

IDCRC Vaccine & Treatment Evaluation Units (VTEUs)

IDCRC Concept Quick Stats

ICP Status

  • Approved: 26
  • Administratively Not Supported: 16
  • Revise & Resubmit: 7
  • Withdrawn: 7
  • Liaisons: 2
  • EWGs: 4
  • Not Approved: 28
  • EMT: 1
  • Other: 6

EWG Assignment

  • COVID: 71
  • Respiratory: 10
  • STI: 5
  • Malaria/Topical Diseases: 4
  • Enteric Infections: 2
  • Emerging Infections: 5

ECP

  • Protocol Development: 6
  • IDCRC Concept Study Underway: 2
  • Submitted to ACTIVE Mab Program per DMID: 1
  • Transitioned to CoVPN Trial: 1
  • Transitioned to ACTT 2: 1
  • Funded by NIAID via Other Mechanism: 1
  • Pending: 5
  • Not Approved: 0
  • In Process: 5
  • On Hold/Withdrawn: 7
  • Note: Protocols Transitioned to IDCRC for Protocol Implementation: 5

IDCRC Citation Statement


Please include the following citation in any publications resulting from direct or indirect IDCRC support:

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

 

Publications